AM BIOTECHNOLOGIES, LLC
Unified Process proteomics platform for protein biomarker discovery combining bead-based X-Aptamer selection, flow cytometry, and mass spectrometry
- Sector
- Biotech
- Total capital
- $2.9M
- Federal grants
- $1.6M
- 4 awards · 2015–2020
- Rank in peer group#22 of 37
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $1.3M
- 5 awards · NASA, Health and Human S, Defense
- Rank in Biotech#167 of 4373
- Granted patents
- 2
- first 2017
- Rank in peer group#7 of 37
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Unified Process for the Discovery of Protein Biomarkers and their X-Aptamer Affinity Reagents$119K
- Federal grantHealth and Human S · Phase I · Unified Process for the Discovery of Protein Biomarkers and their X-Aptamer Affinity Reagents$186K
- Federal grantHealth and Human S · Phase II · X-Aptamer Selection Kit$559K
- Federal grantHealth and Human S · Phase II · X-Aptamer Selection Kit$701K
- Federal contractDefense · Igf::ot::igf - SBIR Ph I - Topic: Universal Antivenom$100K
- Federal contractNASA · With The Retirement Of The Space Shuttle, Biological Sample Return From The International Space Station (iss) Will Be Challenging Due To Volume Limitations On Soyuz. Based On Advanced Technologies Developed By NASA And Other Organizations, This Project Identifies High Priority Analytes To Be Measured And Validated Against A Laboratory Gold Standard (i.e. Elisa, Other Comparable Assay Detection Methods) In Phase III Development By Am Biotechnologies That Will Show Feasibility For Potential On-orb$150K
- Federal contractNASA · Am Biotechnologies (am) In Partnership With Sandia National Laboratories Will Develop A Thioaptamer Diagnostic System (tds) In Response To Topic X10.01 Reusable Diagnostic Lab Technology. The Tds Will Quickly Quantify Clinically Relevant Biomarkers In Flight Using Only Microliters Of Virtually Any Complex Sample. The System Combines Ambient-stable, Long-shelf-life Affinity Agent Assays With A Handheld Microfluidic Gel Electrophoresis Affinity Assay Quantification Technology. The System Is Easy T$750K
Show 2 earlier federal awards
- Federal contractHealth and Human S · TAS::75 0893::TAS Thioaptamer Capture For Addiction-relevant Proteins$200K
- Federal contractNASA · Am Biotechnologies (am) Will Develop A Diagnostic System In Response To SBIR Topic X10.01 Reusable Diagnostic Lab Technology That Will Simultaneously Detect And Quantify Numerous Protein Biomarkers With Excellent Sensitivity. Am Will Enhance The Current Clinical Gold Standard Immunoassay Methodology By Using Its Proprietary Bead-based Aptamer Selection Process To Select Dithiophosphate Backbone-modified (PS2) "thio" Aptamers (PS2-THIOAPTAMERS) As Replacements For Antibodies In Immunoassays. The $100K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 37 peers
Line = medianBiotech · Platform
- Federal grantsBelow median
- Granted patents#7 · top 19%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 2- GrantedMethods Of X-aptamer Generation And Compositions ThereofUSPTOUS 9,988,623
- GrantedMethods and Compositions of Improved Modified siRNAUSPTOUS 9,629,867
Related companies, and why
- GELSANA THERAPEUTICS INCSimilar federal contract value in Biotech · $1.3M in contracts
- Schrodinger, Inc.Similar federal contract value in Biotech · $1.3M in contracts
- OMICRON BIOCHEMICALS, INC.Similar federal contract value in Biotech · $1.3M in contracts
- CYTOBANK, INC.Similar federal contract value in Biotech · $1.3M in contracts
- MIRIMUS, INC.Similar federal contract value in Biotech · $1.3M in contracts
- CONSEGNA PHARMA INCSimilar federal contract value in Biotech · $1.3M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .